A detailed history of Lgt Group Foundation transactions in Eli Lilly & CO stock. As of the latest transaction made, Lgt Group Foundation holds 303,156 shares of LLY stock, worth $241 Million. This represents 4.43% of its overall portfolio holdings.

Number of Shares
303,156
Previous 394,553 23.16%
Holding current value
$241 Million
Previous $357 Million 24.81%
% of portfolio
4.43%
Previous 5.47%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$772.14 - $960.02 $70.6 Million - $87.7 Million
-91,397 Reduced 23.16%
303,156 $269 Million
Q2 2024

Aug 07, 2024

BUY
$724.87 - $909.04 $181 Million - $227 Million
249,272 Added 171.58%
394,553 $357 Million
Q1 2024

May 14, 2024

SELL
$592.2 - $792.28 $42.1 Million - $56.3 Million
-71,041 Reduced 32.84%
145,281 $113 Million
Q4 2023

Feb 06, 2024

SELL
$525.19 - $619.13 $1.67 Million - $1.97 Million
-3,182 Reduced 1.45%
216,322 $126 Million
Q3 2023

Nov 06, 2023

SELL
$434.7 - $599.3 $920,694 - $1.27 Million
-2,118 Reduced 0.96%
219,504 $118 Million
Q2 2023

Jul 27, 2023

BUY
$350.74 - $468.98 $1.38 Million - $1.84 Million
3,921 Added 1.8%
221,622 $104 Million
Q1 2023

Apr 20, 2023

SELL
$310.63 - $364.82 $3.86 Million - $4.53 Million
-12,430 Reduced 5.4%
217,701 $74.8 Million
Q4 2022

Feb 09, 2023

BUY
$321.55 - $374.67 $13.9 Million - $16.2 Million
43,198 Added 23.11%
230,131 $84.2 Million
Q3 2022

Oct 19, 2022

SELL
$296.48 - $337.87 $7.12 Million - $8.11 Million
-24,013 Reduced 11.38%
186,933 $60.4 Million
Q2 2022

Aug 03, 2022

BUY
$278.73 - $327.27 $13.3 Million - $15.6 Million
47,816 Added 29.31%
210,946 $68.4 Million
Q1 2022

May 11, 2022

BUY
$234.69 - $291.66 $10.1 Million - $12.6 Million
43,046 Added 35.85%
163,130 $47.7 Million
Q4 2021

May 03, 2022

BUY
$224.85 - $279.04 $27 Million - $33.5 Million
120,084 New
120,084 $33.2 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Lgt Group Foundation Portfolio

Follow Lgt Group Foundation and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lgt Group Foundation, based on Form 13F filings with the SEC.

News

Stay updated on Lgt Group Foundation with notifications on news.